OSR Health Clarifies Nasdaq Communications Regarding Shareholder Loyalty CVR Program
On August 7, 2026, OSR Health, Inc. issued a press release to clarify previous communications regarding its Shareholder Loyalty Contingent Value Rights (CVR) program and The Nasdaq Stock Market LLC. The company clarified that a July 31, 2026, press release should not be interpreted as an endorsement or approval of the CVR program by Nasdaq. According to the filing, Nasdaqβs involvement was limited to a preliminary, verbal indication regarding a technical question on whether the program would trigger a mechanical adjustment to the company's common stock price (such as an ex-date adjustment). Nasdaq has not expressed a definitive opinion on any other aspect of the program. Despite this clarification, the company confirmed that the previously announced record date for the CVR program remains August 14, 2026. OSR Health continues to navigate regulatory and securities-law processes, including a pending SEC no-action request related to the loyalty program.